Coxarthrosis Clinical Trial
Official title:
Comparison of Hyaluronic Acid and Corticosteroid Intra-articular Injections for the Treatment of Osteoarthritis of the Hip Controlled With Intra-articular Injections With Bupivacaine
Abstract Background: The effect of intra-articular treatment of hip osteoarthritis with
hyaluronic acid in the hip joint is not based on large randomized controlled trials.
Hyaluronic acid is a well established treatment for osteoarthritis of the knee.
Methods: Randomized controlled trial with three-armed parallel-group design. The patients
meeting the inclusion criteria will be randomized into one of the following groups:
infiltration of the hip joint with hyaluronic acid, with corticosteroids or with bupivacaine
0,125%.
Pain VAS, Harris Hip Score and HOOS were scored during follow-up. The patients will be asked
to determine their situation as worse, stabile or better then at the time of enrollment.
There will be asked if they use painkillers and if they have complications/adverse events.
These outcome measure instruments will be used at the time of enrollment in the study prior
to any injection, and then again at six weeks, 3 and 6 months after the initial injection.
The six-month follow-up period begins for all patients on the date the first injection will
be administered.
Status | Not yet recruiting |
Enrollment | 489 |
Est. completion date | December 2013 |
Est. primary completion date | July 2012 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 30 Years to 70 Years |
Eligibility |
Inclusion Criteria: 1. an age between 30 and 70years 2. radiographic evidence of OA of the hip (Kellgren-Lawrence grading scale 1-3) 3. chronic pain for at least 3 months prior to study entry (day 0) 4. dissatisfaction with prior attempts at non-operative management including nonsteroidal anti-inflammatory drugs. Exclusion Criteria: 1. Kellgren and Lawrence grade 4 2. an intra-articular hip injection (with any corticosteroid, hyaluronic acid preparation or other) within the previous three months 3. non compliance to the study procedures and or non completion of the study according to investigator's judgment 4. rapid destructive hip. 5. a history of crystalline arthropathy or inflammatory arthritis, neuropathic arthropathy 6. a current other problem in the affected extremity 7. contra-indications for the use of corticosteroids (gastrointestinal ulcer, severe osteoporosis, psychiatric anamnesis, herpes simplex or zoster (viremic stadium), varicella, 8 weeks before and 2 weeks after immunization, systemic mycosis, poliomyelitic except of bulbar encephalitic form lymphadenitis after BCG-vaccination, parenteral depot medication, closed- and wide-angle glaucoma) 8. allergy or hypersensitivity to any of the study medications or to contrast solutions. |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
Country | Name | City | State |
---|---|---|---|
Belgium | University Hospital Pellenberg | Leuven |
Lead Sponsor | Collaborator |
---|---|
University Hospital Pellenberg |
Belgium,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Harris Hip Score | this score will be used as a self-administered questionnaire in accordance with the developers' instructions. The Harris Hip Score was first developed in 1967 and is accepted as one of the best used questionnaires dealing the hip function. It is a disease-specific scoring system which was introduced to provide an evaluation system for various hip disabilities and methods of treatment. This Score gives a maximum of 100 points, with domains of pain, function, deformity and motion. | 0 - 6 - 12 - 26 weeks | No |
Secondary | Visual Analog Score | this score is a self-assessment of variation in pain intensity, measured on a simple 100-mm-long continuous scale of absolutes ranging from "no pain" to "extreme pain". The percentage of pain is determined by physical measuring from the end of the line to the patients' mark on the pain scale, and divided by total length of the line. The advantage of the VAS is that you can determine the change in pain by taking the difference between any two recordings of pain severity | 0 - 6 - 12 - 26 weeks | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT01326832 -
10 Year Clinical Evaluation of Primoris Hip Component
|
||
Completed |
NCT02399670 -
The Influence of Global Femoral-offset Changes After Total Hip Arthroplasty
|
N/A | |
Completed |
NCT01046019 -
Measurement of Early Bone Loss Around a Total Hip Arthroplasty
|
N/A | |
Completed |
NCT00159497 -
Bone Remodeling Around HA-coated Acetabular Cups.
|
Phase 4 | |
Not yet recruiting |
NCT04570748 -
Effect of Capsular Repair on the Outcomes of Direct Anterior Total Hip Arthroplasty.
|
N/A | |
Completed |
NCT00317889 -
Compaction Total Hip Arthroplasty (THA) Bilateral
|
N/A | |
Recruiting |
NCT04424628 -
Radiotherapy 3 vs 6 Gy in Gonarthrosis and Coxarthrosis
|
N/A | |
Not yet recruiting |
NCT06272422 -
Comparison of the Restoration of Hip Biomechanical Parameters by CT Measurement Between the 3 Surgical Techniques: RSA/Minihip/THA - Hip Replacement: 3D Planning
|
||
Completed |
NCT02694146 -
Clinical Trial to Evaluate the Use of Platelet Rich Plasma in Front Hyaluronic Acid in Coxarthrosis
|
Phase 3 | |
Completed |
NCT02719236 -
Direct Anterior Approach Versus Direct Lateral Approach in Total Hip Arthroplasty
|
N/A | |
Completed |
NCT05343195 -
Balance and Leg Function After Hip Replacement
|
N/A | |
Completed |
NCT01279174 -
Galileo-Hip Whole Body Vibration /Conventional Physiotherapy /Coxarthrosis
|
Phase 4 | |
Active, not recruiting |
NCT00318396 -
Compaction Femur Preparation for Cementless Total Hip Arthroplasty (THA) Unilateral
|
N/A | |
Completed |
NCT02338596 -
Ultra-Short Anatomic and Conventional Cementless Stems Cementless Stems in Patients Younger Than Fifty-Five Years Old
|
Phase 4 | |
Active, not recruiting |
NCT00722982 -
Migration Pattern of C-stem AMT Versus Exeter in Total Hip Arthroplasty
|
N/A | |
Completed |
NCT04903860 -
Comparison of the Use of Conventional Ancillary Reaming and Single-use Ancillary Reaming Material in Total Hip Replacement
|
N/A | |
Recruiting |
NCT04317872 -
Effect of Peri-operative Glucocorticoids on Short-term Functional Outcome After THA
|
N/A | |
Recruiting |
NCT03809962 -
Efficacy and Safety of Ostenil® Plus in the Treatment of Coxarthrosis
|
||
Active, not recruiting |
NCT01578746 -
Comparison Between Anterior and Direct Lateral Approach in Total Hip Arthroplasty
|
Phase 4 | |
Completed |
NCT00317863 -
Zink and Bone Strength
|
N/A |